Jefferson University Hospitals

Provider Profile

Steven E. McKenzie, MD

Steven E. McKenzie, MD

Jefferson University Physician

Academic Title: Professor
Director, Division of Hematology

Specialties
Hematology (Not Accepting New Patients)
Pediatrics - Hematology/Oncology

Make An Appointment

Click to call 1-800-JEFF-NOW (800-533-3669) or

Office Locations

Philadelphia
1015 Chestnut Street
Suite 1020
Philadelphia PA 19107
Phone: (215) 955-4730
Fax: (215) 503-9188

Medical Services

Years in Practice

27

Board Certifications

  • Pediatric Hematology-Oncology
  • Pediatrics

Hospital Affiliation / Admitting Privileges

  • Thomas Jefferson University Hospital

Education

  • University of Pennsylvania School of Medicine, Medical School

Internship

  • Children's Hospital of Philadelphia

Residency

  • Children's Hospital of Philadelphia

Fellowship

  • Children's Hospital of Philadelphia

Jefferson physicians accept most health insurance plans, including those listed below. However, plan acceptance may vary by practice and may be subject to change. If you have questions about whether a specific physician accepts your insurance, please contact your insurance company.

Insurances Accepted

  • Aetna
  • Amerihealth Caritas
  • Blue Cross/Blue Shield
  • Cigna Healthspring
  • Cigna PPO, POS
  • CorVel
  • Coventry/Health America
  • Devon
  • Evolutions (Guardian Resources)
  • Galaxy
  • Geisinger Health Plan
  • Health America PPO
  • Horizon Blue Cross/Blue Shield
  • HumanaChoicePPO,Medicare,GoldPlusHMO
  • Intergroup Preferred
  • Jeff Plus
  • Keystone 65 HMO
  • Keystone Health Plan East
  • Medicaid of PA
  • Medicare
  • MultiPlan Inc.
  • NJ Blue Shield
  • Personal Choice (GPPPN)
  • Personal Choice 65
  • PlanCare America
  • PPO Next
  • Preferred Care PPO
  • Qualcare

Recent Publications

Platelets release pathogenic serotonin and return to circulation after immune complex-mediated sequestration

5B9, a monoclonal antiplatelet factor 4/heparin IgG with a human Fc fragment that mimics heparin-induced thrombocytopenia antibodies

Erratum: TULA-2 protein phosphatase suppresses activation of Syk through the GPVI platelet receptor for collagen by dephosphorylating Tyr(P)346, a regulatory site of Syk (The Journal of Biological Chemistry (2016) 291 (22427-22441) DOI: 10.1074/jbc.M116.743732)

Endothelial antigen assembly leads to thrombotic complications in heparin-induced thrombocytopenia

TULA-2 (T-Cell Ubiquitin Ligand-2) Inhibits the Platelet Fc Receptor for IgG IIA (FcγRIIA) Signaling Pathway and Heparin-Induced Thrombocytopenia in Mice

TULA-2 protein phosphatase suppresses activation of syk through the GPVI platelet receptor for collagen by dephosphorylating Tyr(P)346a regulatory site of syk

Mice expressing low levels of CalDAG-GEFI exhibit markedly impaired platelet activation with minor impact on hemostasis

Identification of novel Syk-independent functional roles of FcγRIIa in platelet outside-in signaling using transgenic mice expressing human FcγRIIa

Syk inhibition in ischemic stroke

Platelet transactivation by monocytes promotes thrombosis in heparin-induced thrombocytopenia

The antigenic complex in HIT binds to B cells via complement and complement receptor 2 (CD21)

Anti-miR-148a regulates platelet FcγRIIA signaling and decreases thrombosis in vivo in mice

Analysis of 13 cell types reveals evidence for the expression of numerous novel primate- And tissue-specific microRNAs

Platelet 12-LOX is essential for FcγRIIa-mediated platelet activation

MicroRNA expression differences in human hematopoietic cell lineages enable regulated transgene expression

Human platelet microRNA-mRNA networks associated with age and gender revealed by integrated plateletomics

The human platelet: Strong transcriptome correlations among individuals associate weakly with the platelet proteome

Identification of a developmental gene expression signature, including hox genes, for the normal human colonic crypt stem cell niche: Overexpression of the signature parallels stem cell overpopulation during colon tumorigenesis

Advances in the pathophysiology and treatment of heparin-induced thrombocytopenia

Protein kinase C δ deficiency enhances megakaryopoiesis and recovery from thrombocytopenia